{"prompt": "['FLUAD vs Fluzone-HD', 'Version 5.0', 'September 25, 2018', '10. To describe the immunogenicity of allV3 and IIV3-HD', 'after repeat administration of the same product over 2', 'consecutive influenza seasons in a subset of subjects', '11. To assess changes in serum hemagglutination', 'inhibition at 1 month after allV3 and IIV3-HD', 'vaccination and at 6 months after vaccination in a', 'subset of subjects', 'Outcome Measures:', 'Primary:', '1. Comparison of the proportion of subjects reporting', 'moderate/severe injection site pain within the first week', 'post-vaccination in both treatment groups.', '2. The frequency and descriptions of serious adverse', 'events and adverse events of clinical interest observed', 'in the two treatment cohorts', '3. H3N2 HAI seroconversion: The proportion of subjects', 'achieving H3N2 seroconversion at day 29 (an HAI titer', '> 1:40 at day 29 if the baseline titer is < 1:10 or a', 'minimum four-fold rise in HAI titer if the baseline titer is', \"> 1:10) in the respective season's vaccine\", 'Secondary', '1. Comparison of local and systemic reactions within the', 'first week post-vaccination in both treatment groups.', '2.', 'Change in scores on the Late Life Function & Disability', 'Instrument (Year 1 only), EuroQOL 5 dimensions-5', 'level (EQ-5D-5L) and EuroQOL visual analogue scale', '(EQ VAS) pre-vaccination and post-vaccination will be', 'compared between the vaccination groups and age', 'groups.', '3. HAI titers:', 'a. The proportion of subjects achieving', 'seroconversion at day 29 (an HAI titer > 1:40 at', 'day 29 if the baseline titer is < 1:10 or a', 'minimum four-fold rise in HAI titer if the baseline', 'titer is > 1:10) for H1N1 and influenza B and', 'H3N2 (by age group only) in the respective', \"season's vaccine\", 'b. Proportion of subjects with a seroprotective HAI', 'titer (= 1:40) pre- and post-immunization at day', '29 for each IIV antigen in the respective', \"season's vaccine The geometric mean HAI titer\", '(GMT) for each IIV antigen in the respective', \"season's vaccine\", 'C. The geometric mean HAI titer (GMT) for each IIV', \"antigen in the respective season's vaccine\", '8']['FLUAD vs Fluzone-HD', 'Version 5.0', 'September 25, 2018', 'Exploratory:', '1. Associations between moderate/severe local and', 'systemic reactogenicity events and quality of life', 'outcomes in the full study population and by age group', '2. Comparison between vaccination groups of proportion', 'of participants with negative and positive perceptions of', 'the vaccination experience based on responses to the', 'Perceptions of Vaccination Experience questionnaire', '3. Proportion of participants with difficulty performing', 'adverse event monitoring based on responses to', 'questions to the Perceptions of Vaccination Experience', 'questionnaire', '4. Mean injection site pain scores immediately after', 'vaccination in both vaccination groups using the Faces', 'Pain Scale', '5. Compare the frequency and descriptions of immediate', 'reactogenicity and immediate serious adverse events', 'and adverse events of clinical interest between', 'vaccination groups.', '6. Associations between reactogenicity and demographic,', \"co-morbidity and medication factors from subjects'\", 'medical histories, including statin use', '7. Compare changes in local and systemic reactions in', 'subjects who receive vaccine in both study years', '8. Associations between HAI titers and moderate/severe', 'local and systemic reactogenicity events.', '9. Associations between HAI titers and demographic, co-', \"morbidity and medication factors in subjects' medical\", 'histories including statin use', '10. Comparison of seroprotection and seroconversion as', 'defined by HAI titers and geometric mean HAI titers in', 'subjects who receive vaccine in both study years', '11. Comparison of seroprotection and seroconversion as', 'defined by HAI titers and geometric mean HAI titers', 'between 1 month and 6 months in the same subjects', '(Year 1 only)', 'Estimated Time to Complete', 'Approximately 6 months for enrollment during each of two', 'Enrollment:', 'consecutive flu seasons, for an overall duration of 18 months', '9']\n\n###\n\n", "completion": "END"}